Granules India Limited received approval from Brazilian Health Regulatory Agency ANVISA

Granules India Limited has received the approval from Brazilian Health Regulatory Agency (ANVISA), for compliance with the guidelines of Good Manufacturing Practices for its Bonthapally facility, located at Bonthapally Village, Gummadidala Mandal, Sangareddy District, Hyderabad, Telangana.

Bonthapally facility manufactures Active Pharmaceutical Ingredients (API).

Shares of Granules India Limited was last trading in BSE at Rs. 294.80 as compared to the previous close of Rs. 294.55. The total number of shares traded during the day was 26361 in over 746 trades.

The stock hit an intraday high of Rs. 299.50 and intraday low of 294.00. The net turnover during the day was Rs. 7834891.00.

Source : Equity Bulls

Keywords

GranulesIndia INE101D01020 ANVISA GMPCompliance Approval Brazil